Clinical Trial Update: HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating HLA-mismatched unrelated donor hematopoietic cell transplantation with post-transplantation cyclophosphamide is active but not recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Chronic Lymphocytic Leukemia
• Leukemia
• Lymphoma
• Mixed Phenotype Acute Leukemia
• Myelodysplastic Syndromes
• Myelogenous Leukemia

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: Center for International Blood and Marrow Transplant Research | Conditions: Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia | Phase 2 | Status: ACTIVE_NOT_RECRUITING